RNAble is developing a small molecule modifier of RNA stability to treat cancer and rare diseases

Scientific approach

Inhibition of specific epitranscriptomic modifiers can lead to stabilization of various RNA molecules. In the case of mutated RNA transcripts, such stabilization may prevent nonsense mediated decay (NMD). This can potentially lead to expression of partially functional proteins in the case of various rare diseases, or to increase in RNA load in NMD-dependent cancers.

link to RNAble page


AML, rare disease


Prof. Rotem Karni – Inventor

Amir Mor, PhD – CSO

Scroll to top